DelveInsight’s “Trigeminal Neuralgia Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Trigeminal Neuralgia (TN), historical and forecasted epidemiology as well as the Trigeminal Neuralgia market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
The Trigeminal Neuralgia market report provides current treatment practices, emerging drugs, Trigeminal Neuralgia market share of the individual therapies, and current and forecasted Trigeminal Neuralgia market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Trigeminal Neuralgia treatment practices/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Trigeminal Neuralgia market.
Some of the key facts of the Trigeminal Neuralgia Market Report:
A study conducted by Majeed et al. (2018) stated that due to the episodic nature of TN, its initial presentation and the long-term management of the patients fall under the care of general practitioners (GPs). A survey of the GPs in the United Kingdom reported the incidence of TN as 26 per 100,000 per year, between 1992–2002. The National Institute of Neurological Disorders and Stroke estimates the incidence rate of 12 per 100,000 people per year. There is gender variability in the incidence of TN with a female-to-male ratio of 1.74:1 with most of the cases occurring after 50 years.
A study conducted by Manzoni et al. (2005) in Italy stated that trigeminal neuralgia has an incidence ranging from about 4–5 per 100,000 per year up to 20 per 100,000 per year after age 60. The female-to-male ratio is about 3:2.
According to a study by Lambru et al. (2020), the lifetime prevalence of TN is estimated to be 0.16%–0.3%, while the annual incidence is 4–29 per 100 000 person-years. It is more prevalent in women than in men. The incidence increases with age, with a mean age of onset of 53–57 years and a range of 24–93 years in the adult series.
Key Benefits of the Report:
The report covers the descriptive overview of Trigeminal Neuralgia), explaining its causes, signs and symptoms, pathophysiology, diagnosis, and currently available therapies
Comprehensive insight has been provided into the Trigeminal Neuralgia epidemiology and treatment in the 7MM
Additionally, an all-inclusive account of both the current and emerging therapies for Trigeminal Neuralgia is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
A detailed review of the Trigeminal Neuralgia market; historical and forecasted is included in the report, covering drug outreach in the 7MM
The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Trigeminal Neuralgia market
Got queries? Click here to know more about the Trigeminal Neuralgia Market Landscape
Trigeminal Neuralgia Overview
Trigeminal Neuralgia, also known as tic douloureux, is a chronic pain condition that affects the trigeminal or fifth cranial nerve, one of the most widely distributed nerves in the head. It is a form of neuropathic pain (pain associated with nerve injury or nerve lesion) and is categorized in two types: primary (idiopathic) and secondary. The typical or “classic” form of the disorder called TN1 causes extreme, sporadic, sudden burning or shock-like facial pain that lasts anywhere from a few seconds to as long as two minutes per episode. These attacks can occur in quick succession, in volleys lasting as long as 2 hours. The “atypical” form of the disorder is characterized by constant aching, burning, and stabbing pain of somewhat lower intensity than Type 1. Both forms of pain may occur in the same person, sometimes at the same time. The intensity of pain can be physically and mentally incapacitating. TN occurs most often in people over age 50, although it can occur at any age, including infancy. The possibility of TN being caused by multiple sclerosis increases when it occurs in young adults. The incidence of new cases is approximately 12 per 100,000 people per year; the disorder is more common in women than in men.
Trigeminal Neuralgia Epidemiology Insights:
Trigeminal neuralgia (TN) is defined by the International Headache Society as a “unilateral disorder characterized by brief electric shock-like pains, abrupt in onset and termination, and limited to the distribution of one or more divisions of the trigeminal nerve.”
As per the National Organization for Rare Disorders (NORD), trigeminal neuralgia affects females slightly more often than males. Although the exact incidence is unknown, approximately 10,000–15,000 new cases occur each year in the United States.
A study conducted by Obermann M (2010) in Germany indicated that the incidence of trigeminal neuralgia is 4.3 per 100,000 persons per year, with a slightly higher incidence for women (5.9 per 100,000) as compared to men (3.4 per 100,000). There is a lack of certainty regarding the etiology and pathophysiology of TN.
Trigeminal Neuralgia Epidemiological Segmentation
Trigeminal Neuralgia incident cases
Trigeminal Neuralgia gender-specific cases
Trigeminal Neuralgia age-specific cases
Trigeminal Neuralgia Market Outlook
The Trigeminal Neuralgia market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Trigeminal Neuralgia market trends by analyzing the impact of current Trigeminal Neuralgia therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of the Trigeminal Neuralgia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Trigeminal Neuralgia market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Trigeminal Neuralgia (TN) market in 7MM is expected to witness a major change in the study period 2019-2032.
Learn more by requesting for sample @ Trigeminal Neuralgia Market Landscape
Table of Contents
Key Insights
Report Introduction
Executive Summary of Trigeminal Neuralgia Market
Disease Background and Overview
Epidemiology and patient population
Trigeminal Neuralgia Market Emerging Therapies
Market Access and Reimbursement of Therapies
Appendix
Trigeminal Neuralgia Market Report Methodology
DelveInsight Capabilities
Disclaimer
About DelveInsight
Click here to read more about Trigeminal Neuralgia Market Landscape
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Shruti ThakurEmail: Send EmailPhone: +91 9568243403Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com
